Chromosomal Imbalance in the Progression of High-Risk Non-Muscle Invasive Bladder Cancer Editorial Comment

被引：0
|
作者：
Montie, James E.
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 03期
关键词：
D O I：
10.1016/j.juro.2009.11.100
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：938 / 939
页数：2
相关论文
共 50 条
  • [41] The long term outcome of high risk non-muscle invasive bladder cancer
    Thomas, F.
    Rubin, N.
    Goepel, J.
    Abbod, M. F.
    Rosario, D.
    Catto, J. W. F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E965 - U26
  • [42] Value of Fluorescence Cystoscopy in High Risk Non-muscle Invasive Bladder Cancer
    Mayr, Roman
    Burger, Maximilian
    CURRENT UROLOGY REPORTS, 2013, 14 (02) : 90 - 93
  • [43] Value of Fluorescence Cystoscopy in High Risk Non-muscle Invasive Bladder Cancer
    Roman Mayr
    Maximilian Burger
    Current Urology Reports, 2013, 14 : 90 - 93
  • [44] Re: Comparative Outcomes of Primary, Recurrent, and Progressive High-Risk Non-Muscle-Invasive Bladder Cancer Editorial Comment
    Wood, David P.
    JOURNAL OF UROLOGY, 2014, 191 (02): : 349 - 349
  • [45] Editorial Comment on "Sequential Intravesical Chemotherapy for Treatment Naïve, High-Risk Non-Muscle Invasive Bladder Cancer: Oncologic Outcomes, Tolerance, and Comparison to Contemporary Controls"
    Richards, Kyle A.
    UROLOGY, 2024, 192 : 67 - 68
  • [46] UNMET NEEDS IN HIGH-RISK NON-MUSCLE INVASIVE AND LOCALIZED MUSCLE INVASIVE BLADDER CANCER: A SYSTEMATIC LITERATURE REVIEW IN THE FRENCH SETTING
    Caron, A.
    Baffert, S.
    Theuillon, T.
    Heng, C.
    Prenaud, M.
    Schaetz, D.
    Lelarge, Y.
    VALUE IN HEALTH, 2024, 27 (12) : S587 - S587
  • [47] Bladder tumor Resection Weight as a Prognostic Factor for Recurrence and Progression in Patients With High-Risk Non-Muscle Invasive Bladder Treated With BCG
    Hald, Oliver C.
    Phan, Yih Chyn
    Carter, Charles J. M.
    Klatte, Tobias
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : e70 - e77
  • [48] SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR BCG-NAIVE HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER
    McElree, Ian M.
    Steinberg, Ryan L.
    Martin, Alexander C.
    Richards, Jordan
    Mott, Sarah L.
    Gellhaus, Paul T.
    Nepple, Kenneth G.
    O'Donnell, Michael A.
    Packiam, Vignesh T.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E488 - E488
  • [49] Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer
    Fahmy, Mona
    Mansure, Jose Joao
    Brimo, Fadi
    Yafi, Faysal A.
    Segal, Robert
    Althunayan, Abdulaziz
    Hicks, Jessica
    Meeker, Alan
    Netto, George
    Kassouf, Wassim
    HUMAN PATHOLOGY, 2013, 44 (09) : 1766 - 1772
  • [50] Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer
    Audenet, Francois
    Farkas, Adam M.
    Anastos, Harry
    Galsky, Matthew D.
    Bhardwaj, Nina
    Sfakianos, John P.
    WORLD JOURNAL OF UROLOGY, 2018, 36 (11) : 1741 - 1748
12345